Levodopa (L Dopa)
7020
relevant articles (708 outcomes,
903 trials/studies)
found for this Drug
Description:
The naturally occurring form of DIHYDROXYPHENYLALANINE and the immediate precursor of DOPAMINE. Unlike dopamine itself, it can be taken orally and crosses the blood-brain barrier. It is rapidly taken up by dopaminergic neurons and converted to DOPAMINE. It is used for the treatment of PARKINSONIAN DISORDERS and is usually given with agents that inhibit its conversion to dopamine outside of the central nervous system.
Also Known As:
L Dopa; Larodopa; 3-Hydroxy-L-tyrosine; Dopaflex; Dopar; L-3,4-Dihydroxyphenylalanine; Levopa; Medphano Brand of Levodopa; Roberts Brand of Levodopa; Roche Brand of Levodopa; 3 Hydroxy L tyrosine; L 3,4 Dihydroxyphenylalanine; L-Dopa
Relationship Network
Drug Context: Research Results